Barclays maintains DR Horton at 'overweight' with a price target of $150.00

  • Investing.com
Barclays maintains DR Horton at 'overweight' with a price target of $150.00

An analyst from Barclays maintained DR Horton (NYSE: DHI ) at 'overweight' with a price target of $150.00 from a prior price target of $138.00.

Prior to this rating, DR Horton had 11 buy ratings, 10 hold ratings, and 1 sell ratings.

For consensus analyst estimates and price targets on DR Horton, click here. For more news on DR Horton, click here.

DR Horton's stock price closed at $125.42. They are up 4.84% in the last month and up 62.06% in the last 12 months.

According to Investing Pro, DR Horton's fair value is $155.41, an upside of 23.91%. DR Horton's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out DR Horton's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100